Global Antibody Drug Conjugates Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
The Global Antibody Drug Conjugates Market Report by The Business Research Company covers antibody drug conjugates market drivers and restraints, antibody drug conjugates market size, major players, and the impact of COVID-19 on the antibody drug conjugates market.
The antibody-drug conjugates (ADCs) market consists of sales of antibody-drug conjugates. ADCs are complex engineered therapeutics consisting of monoclonal antibodies, directed toward tumor-associated antigens, to which highly potent cytotoxic agents are attached using chemical linkers.
The antibody drug conjugates market is being driven by rising incidences of cancer globally. The global antibody drug conjugates market is expected to grow from $2.34 billion in 2020 to $2.6 billion in 2021 at a compound annual growth rate (CAGR) of 11.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The antibody-drug conjugates (ADCs) market is expected to reach $6.12 billion in 2025 at a CAGR of 23.9%.
Request A Sample For The Global Antibody Drug Conjugates Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp
Some antibody drug conjugates market trends include manufacturers of antibody drug conjugates are increasingly collaborating or partnering with other companies to share technology, resources, product knowledge and expand business
Global antibody drug conjugates market segments include:
1) By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Others.
2) By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Others.
3) By Product: Adcertis, Kadcyla, Others.
4) By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Others.
5) By End User: Hospital, Clinics, Others.
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030 At:
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report
The Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides antibody drug conjugates market overviews, analyzes and forecasts market size, share, antibody drug conjugates market players, antibody drug conjugates market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The antibody drug conjugates identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Market Players Covered: Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., ImmunomedicsInc., Oxford BioTherapeutics, Pfizer Inc., Seattle GeneticsInc.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Antibody Drug Conjugates Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The Antibody Drug Conjugates Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Antibody Drug Conjugates Global Market Report 2021:
